Innovation leads the way, poised for takeoff | Focusfreda wins three China invention patents at the beginning of the year

The new year has just begun with a series of positive developments. Recently, the National Intellectual Property Administration officially granted Focusfreda three invention patents, marking a solid step forward in the company's core technological innovation and intellectual property strategy. This achievement injects strong momentum into its annual innovation efforts.

The three patented inventions, all focusing on innovative R&D in biotechnology and the broader health sector, demonstrate Focusfreda's deep expertise and forward-looking vision in cutting-edge interdisciplinary fields.

Patent 1: Serratia marcescens Y3521 for Degradation of Polysaccharides from Tremella fuciformis and Its Cultivation Method and Applications

This invention, for the first time, utilizes Serratia marcescens Y3521 to prepare Auricularia polysaccharidase, which is then employed in the production of low-molecular-weight Auricularia polysaccharides. The enzyme can degrade Auricularia polysaccharides with molecular weights of 1000-2000kDa into fragments below 10 kDa, making it suitable for the preparation of low-molecular-weight Auricularia polysaccharides. It exhibits high specificity for Auricularia polysaccharides and is applicable for industrial production.

This technological breakthrough addresses the bottlenecks of traditional physical and chemical methods for producing Agaricus blazei oligosaccharides, including low efficiency, significant activity loss, and safety concerns. By applying Serratia marcescens in this field, it provides a core enzyme source for large-scale, green production of highly active and easily absorbable Agaricus blazei oligosaccharides, significantly expanding their application depth and breadth in food, pharmaceuticals, health supplements, and cosmetics.

Patent 2: A Sporothrix interspecies strain Y3522 and its application in the production of tremella oligosaccharides

This invention provides another efficient and environmentally friendly biological manufacturing method for Auricularia auricula oligosaccharides. Utilizing Bacillus interspecies Y3522-produced Auricularia polysaccharidase for the production of low-molecular-weight Auricularia polysaccharides, it demonstrates exceptional capability in degrading high-molecular-weight Auricularia polysaccharides (1000-4000 kDa) into oligosaccharides below 20 kDa.

The successful development of this technology signifies that enterprises have acquired a more comprehensive and adaptable set of biological tools, enabling the industrial production of tremella oligosaccharides to eliminate reliance on high-energy-consuming equipment or hazardous chemical reagents. This truly achieves process controllability, mild conditions, and environmental friendliness, laying a solid foundation for enhancing product quality stability and reducing production costs.

Patent No.3: A Compound Microbial Fermentation-based Traditional Chinese Medicine Scalp Care Composition and Its Application

This technology achieves deep integration of modern fermentation techniques with traditional Chinese medicine wisdom. Through an innovative composite microbial fermentation process and the strategic application of stabilization technologies such as cross-linked microspheres, it successfully addresses industry challenges in traditional Chinese medicine fermentation, including the volatility of active ingredients, product contamination risks, and poor storage stability. The resulting nourishing formulation maximizes the retention of natural active components, primarily derived from herbs with properties of tonifying deficiency, clearing heat, and promoting blood circulation. It significantly enhances efficacy in promoting hair follicle growth, inhibiting scalp inflammation, nourishing hair, and preventing or stabilizing hair loss, while remaining safe and non-irritating. This marks a significant breakthrough by Focusfreda in the modern and efficient application of natural plant-derived active ingredients, introducing a high-tech, highly effective solution to the scalp health care market.

The concurrent grant of three invention patents represents Focusfreda's milestone achievement in its long-standing commitment to' R&D-driven, technology-first' philosophy, while providing robust technical support for future product upgrades and market expansion. In 2026, Focusfreda will continue to uphold its innovative spirit, transforming technological advantages into market dominance. Through continuous refinement in product development, market strategies, and service excellence, the company will advance toward a higher-quality future with its solid technological foundation.